Delayed-onset vemurafenib-induced panniculitis
نویسندگان
چکیده
منابع مشابه
Delayed-onset vemurafenib-induced panniculitis
INTRODUCTION Approved in 2011, vemurafenib is a selective serine/threonine kinase inhibitor directed against the V600E mutation in the BRAF gene. This drug is often used in dermatology as a targeted therapy for metastatic or unresectable melanomas, for which about 50% have this mutation. Other tumors possessing the V600E mutation are targets for this therapy. The commonly reported adverse effec...
متن کاملCold panniculitis: delayed onset in an adult.
The panniculitides are a complex dermatologic entity for both dermatologists and dermatopathologists. Panniculitis is an inflammation of the subcutaneous adipose tissue and can be associated with systemic diseases. We present a case of cold panniculitis, a form of traumatic panniculitis, in a 37-year-old woman that was caused by a cold therapy unit. Our patient did not develop lesions until 10 ...
متن کاملSubcutaneous Panniculitis-Like T Cell Lymphoma Mimicking Early-Onset Nodular Panniculitis
BACKGROUND Subcutaneous panniculitis-like T cell lymphoma is a very uncommon subtype of cutaneous T cell lymphoma. The manifestations of this rare disease are atypical at onset, and may mimic some rheumatic or dermatologic diseases, which causes the delay of diagnosis and treatment. CASE REPORT We report a 24-year-old man suffering from intermittent fever and skin nodules on the left anterior...
متن کاملDelayed-Onset Hepatic Encephalopathy Induced by Zolpidem: A Case Report
Hepatic encephalopathy (HE) is a complex neuropsychiatric disorder associated with either hepatocellular insufficiency and/or the presence of porto-systemic shunts. It is thought to be induced by altered neurotransmission mediated by enhanced gamma-aminobutyric acid (GABA)-induced inhibitory tone. The use of benzodiazepines are generally avoided in patients with advanced chronic liver disease (...
متن کاملA Case of Propofol-Induced Delayed-Onset Refractory Myoclonic Seizures
Propofol, a GABA-mediated inhibitor of excitatory neurotransmitter, is a popular intravenous agent for general anesthesia and sedation. Its side effects reportedly include opisthotonus, seizures, and myoclonus, and are usually manageable. We present a patient who developed propofol-induced delayed-onset refractory myoclonic seizures that resisted antiepileptic drugs.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAAD Case Reports
سال: 2017
ISSN: 2352-5126
DOI: 10.1016/j.jdcr.2017.06.001